Loteprednol Etabonate Suspension/ Drops
Product Images NDC 72485-653

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 72485-653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton 10 mL (10ml Carton)

Carton 10 mL (10ml Carton)
This is a description for a medication called Loteprednol Etabonate Ophthalmic Suspension. It is intended for ophthalmic (eye) use only and is sterile. The active ingredient in each milliliter of the suspension is Loteprednol Etabonate at a concentration of 2mg (0.2%). Inactive ingredients include Edetate Disodium, Glycerin, Povidone, Water for Injection, and Tyloxapol. The suspension is isotonic with a tonicity of 250 to 310 mosmol/kg. It also contains a preservative called Benzalkonium Chloride at a concentration of 0.01%. The recommended dosage and storage instructions can be found in the package insert. The medication is distributed by Amas Pharmaceuticals, Inc. in Freehold, NJ, USA and manufactured by Ophtapham AG in Switzerland for Sentiss.*
FDA Label Image

Container 10 mL (10ml Label)

Container 10 mL (10ml Label)
FDA Label Image

Carton 5 mL (5ml Carton)

Carton 5 mL (5ml Carton)
This text appears to describe a medication called Loteprednol Etabonate Ophthalmic Suspension. It is specifically for ophthalmic use only and is sterile. Each milliliter of the suspension contains 2mg (0.2%) of active ingredient Loteprednol Etabonate. The suspension also includes various inactive ingredients such as Edetate Disodium, Glycerin, Povidone, Water for Injection, Tyloxapol, and may have Hydrochloric Acid and/or Sodium Hydroxide added to adjust the pH. The suspension is isotonic and has a tonicity of 250 to 310 mosmol/kg. It contains the preservative, Benzalkonium Chloride, at a concentration of 0.01%. The recommended storage temperature is between 15°C to 25°C (59°F to 77°F) and it should not be frozen. Before use, it is advised to shake the container vigorously. Additionally, it is important to keep this medication out of reach of children and not to use it if the neckband is not intact. The medication is distributed by Armas Pharmaceuticals, Inc. in the USA and manufactured by Ophitapham AG in Switzerland on behalf of Sentiss.*
FDA Label Image

Container 5 mL (5ml Label)

Container 5 mL (5ml Label)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.